Busan, South Korea

Kyoungsun Kim

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kyoungsun Kim: Innovator in Therapeutic Preparations

Introduction

Kyoungsun Kim is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of therapeutic preparations, particularly through his innovative work involving thymosin beta 4. With a total of 4 patents to his name, Kim's inventions focus on enhancing the stability and efficacy of therapeutic agents.

Latest Patents

One of Kyoungsun Kim's latest patents is a "Stabilized external preparation comprising thymosin beta 4 as an active ingredient." This invention relates to a therapeutically effective external preparation that improves the stability and biological activity of thymosin beta 4. The preparation maintains the biological activity of thymosin beta 4 while minimizing the generation of sulfoxide and multimers through oxidation reactions and aggregation. Another significant patent involves "Methods of treating dry eye syndrome," which utilizes thymosin beta 4 and its derivatives to increase tear volume, enhance tear film stability, and reduce ocular discomfort.

Career Highlights

Throughout his career, Kyoungsun Kim has worked with various companies, including G-Treebnt Co., Ltd. and Regentree, LLC. His work has been instrumental in advancing therapeutic solutions that address critical health issues.

Collaborations

Kyoungsun Kim has collaborated with notable individuals in his field, including Sin Wook Kang and Si Young Lee. These partnerships have contributed to the development of innovative therapeutic methods and preparations.

Conclusion

Kyoungsun Kim's contributions to the field of therapeutic preparations highlight his dedication to innovation and improving health outcomes. His work with thymosin beta 4 has the potential to significantly impact the treatment of various conditions, particularly dry eye syndrome.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…